• Phase

    Alumni community member

  • Contact person

    Helene Hartman, CEO

  • Email

    helene.hartman@in2cure.com

  • Area

    Pharma & Biotech

in2cure

in2cure aims to develop novel treatments based on nature’s own defenses – evolutionary old biological systems which normally keep us healthy. It specializes in the development of proprietary peptide-based drugs for prevention and treatment of inflammatory diseases, infections, wound and surgical complications.

Helene holds a Master’s degree in Chemical Engineering from Lund Technical University. She is a strategic leader with 25 years’ experience in product, technology and business development. She as an extensive experience in driving change and reaching results by building bridges between stakeholders, often in complex intercultural environments.

Did you know?

in2cure’s product, BioC, is synthetically produced, but has a sequence identical to those fragments already present in the human body.

© 2020 Copyright SmiLe Incubator